Neuroone Medical Technologies Corp (NMTC) - Total Liabilities

Latest as of March 2026: $2.49 Million USD

Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $2.49 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Neuroone Medical Technologies Corp - Total Liabilities Trend (2010–2025)

This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data. See Neuroone Medical Technologies Corp (NMTC) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Neuroone Medical Technologies Corp Competitors by Total Liabilities

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Slj Global Tbk JK:SULI	Indonesia	Rp486.05 Billion
Barinthus Biotherapeutics plc NASDAQ:BRNS	USA	$24.64 Million
Eduspec Holdings Bhd KLSE:0107	Malaysia	RM32.07 Million
Chariot Oil & Gas Limited F:C62	Germany	€5.39 Million
Inhome Prime Properties SOCIMI S.A. MC:YIPP	Spain	€112.32K
Ntaw Holdings Ltd AU:NTD	Australia	AU$240.37 Million
Veto Switchgears And Cables Limited NSE:VETO	India	Rs1.08 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neuroone Medical Technologies Corp (NMTC) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.

Year	Total Liabilities	Change
2025-09-30	$3.71 Million	-18.36%
2024-09-30	$4.55 Million	+146.11%
2023-09-30	$1.85 Million	-42.58%
2022-09-30	$3.22 Million	+132.43%
2021-09-30	$1.38 Million	-48.60%
2020-09-30	$2.69 Million	+52.16%
2019-09-30	$1.77 Million	-61.64%
2018-09-30	$4.61 Million	+351.02%
2017-09-30	$1.02 Million	+1127.83%
2016-09-30	$83.33K	+134.11%
2015-09-30	$35.59K	+23.14%
2014-09-30	$28.91K	+57.48%
2013-09-30	$18.36K	0.00%
2012-09-30	$18.36K	+7.16%
2011-09-30	$17.13K	+27.33%
2010-09-30	$13.45K	--

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices

Market Cap

$28.49 Million

Market Cap Rank

#23996 Global

#5113 in USA

Share Price

$3.31

Change (1 day)

+1.69%

52-Week Range

$0.59 - $5.11

All Time High

$26.97